It is being investigated for the treatment of obesity and T2DM and could represent a competitive alternative to oral semaglutide, as its less burdensome administration does not require fasting
There were two methods used for internal reference in the included studies, both phosphocreatine/creatine and water-scaling
Whether youre using Ozempic, Wegovy, or Mounjaro, the first 12 weeks can bring intense side effects, especially on weekends
It seems we may be approaching another level with drugs like retatrutide. Furthermore, Novo Nordisk is also joining the Triple G line and reports an average weight loss of about 20% after 24 weeks in a mid-stage study of another experimental drug in China last month
A patient losing 3 pounds per week on 5 mg will have more estrogen disruption than a patient losing 1 pound per week on 15 mg
This is a realistic, common transition experience